How A Pfizer (PFE)-Seagen (SGEN) Deal Would Impact The Health Care Sector

Over the next few years, every time that Pfizer (PFE) reports earnings we're going to be judging their earnings and revenue compared to the last couple of years during Covid when they were selling all of the vaccines, says Brad Loncar. He discusses how Pfizer is in early stage talks to acquire Seagen (SGEN) in a deal that could be worth more than $30B. He talks about how potential headwinds for a Pfizer-Seagen deal and how a Pfizer-Seagen deal would impact the health care sector. He then goes over other health care stocks to watch, highlighting Karuna Therapeutics (KRTX). Tune in to find out more about the stock market today.